Bio Green Med Solution annual operating margin
2009
2010
2011
2012
2013
2014
2015
2016
2018
2023
2024
2025
Bio Green Med Solution's operating margin was −1,128.11% for fiscal 2025.
View full Bio Green Med Solution company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,128.11% | +26788.17 pp |
| 2024 | 2024-12-31 | −27,916.28% | −21856.04 pp |
| 2023 | 2023-12-31 | −6,060.24% | +305.10 pp |
| 2018 | 2018-12-31 | −6,365.33% | −4686.80 pp |
| 2016 | 2016-12-31 | −1,678.53% | −846.74 pp |
| 2015 | 2015-12-31 | −831.79% | +462.15 pp |
| 2014 | 2014-12-31 | −1,293.94% | +364.17 pp |
| 2013 | 2013-12-31 | −1,658.12% | +20230.29 pp |
| 2012 | 2012-12-31 | −21,888.41% | −19635.47 pp |
| 2011 | 2011-12-31 | −2,252.93% | +11260.46 pp |
| 2010 | 2010-12-31 | −13,513.39% | −11504.17 pp |
| 2009 | 2009-12-31 | −2,009.22% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −124.40% | +90975.60 pp |
| Q1 2026 | 2026-03-31 | −31.62% | +14985.62 pp |
| Q3 2025 | 2025-09-30 | −1,224.69% | +16065.63 pp |
| Q3 2024 | 2024-09-30 | −21,770.00% | +21011.25 pp |
| Q2 2024 | 2024-06-30 | −91,100.00% | −89510.46 pp |
| Q1 2024 | 2024-03-31 | −15,017.24% | −13373.24 pp |
| Q4 2023 | 2023-12-31 | −17,290.32% | −15594.23 pp |
| Q3 2023 | 2023-09-30 | −42,781.25% | −40087.72 pp |
| Q2 2023 | 2023-06-30 | −1,589.54% | −672.44 pp |
| Q4 2018 | 2018-12-31 | −1,644.00% | −1169.31 pp |
| Q3 2016 | 2016-09-30 | −1,696.10% | −474.14 pp |
| Q1 2016 | 2016-03-31 | −2,693.53% | −1658.76 pp |
| Q4 2015 | 2015-12-31 | −917.10% | +1423.79 pp |
| Q3 2015 | 2015-09-30 | −474.69% | +296.74 pp |
| Q2 2015 | 2015-06-30 | −1,221.96% | +344.05 pp |
| Q1 2015 | 2015-03-31 | −1,034.77% | +331.40 pp |
| Q4 2014 | 2014-12-31 | −2,340.89% | −1011.79 pp |
| Q3 2014 | 2014-09-30 | −771.43% | +1103.98 pp |
| Q2 2014 | 2014-06-30 | −1,566.01% | +7.47 pp |
| Q1 2014 | 2014-03-31 | −1,366.16% | +544.69 pp |
| Q4 2013 | 2013-12-31 | −1,329.10% | +7939.32 pp |
| Q3 2013 | 2013-09-30 | −1,875.40% | +12786.13 pp |
| Q2 2013 | 2013-06-30 | −1,573.48% | +361.30 pp |
| Q1 2013 | 2013-03-31 | −1,910.85% | −41.71 pp |
| Q3 2012 | 2012-09-30 | −9,268.42% | −6902.57 pp |
| Q2 2012 | 2012-06-30 | −14,661.54% | −12401.42 pp |
| Q1 2012 | 2012-03-31 | −1,934.78% | +565.22 pp |
| Q4 2011 | 2011-12-31 | −1,869.14% | +645.32 pp |
| Q3 2011 | 2011-09-30 | −2,365.85% | +1319.86 pp |
| Q2 2011 | 2011-06-30 | −2,260.12% | — |
| Q1 2011 | 2011-03-31 | −2,500.00% | — |
| Q3 2010 | 2010-09-30 | −2,514.47% | — |
| Q2 2010 | 2010-06-30 | −3,685.71% | — |
Over the last five reported fiscal years, Bio Green Med Solution's operating margin decreased from −831.79% to −1,128.11%, a change of −296.32 percentage points. The latest reported quarter, Q2 2026, shows −124.40%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bio Green Med Solution filings at SEC.gov ↗